Recommended Topic Related To:

Vitrase

"The U.S. Food and Drug Administration today approved Dotarem (gadoterate meglumine) for use in magnetic resonance imaging (MRI) of the brain, spine and associated tissues of patients ages 2 years and older.

Dotarem is a gadolinium-based"...

Vitrase

Vitrase Patient Information including How Should I Take

What should I discuss with my health care provider before receiving hyaluronidase (Vitrase)?

You should not receive this medication if you are allergic to it.

Your doctor may perform a skin test to see if you are allergic to hyaluronidase before you receive the medication.

FDA pregnancy category C. It is not known whether hyaluronidase will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication.

It is not known whether hyaluronidase passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

How should I use hyaluronidase (Vitrase)?

This medication is injected under the skin.

A healthcare provider will give you this injection.

Side Effects Centers
A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.